China has expressed concern over the rapid anti-body test kitsafter the Indian Council of Medical Research (ICMR) said that the results arenot satisfactory and asked the state governments to return the Chinese madetest kits.
ICMR on Monday asked the state governments to return the testkits brought from two Chinese firms Guangzhou Wondfo Biotech and Zhuhai LivzonDiagnostics after several questioned the efficacy of the kits.
In a statement issued by the ICMR, it stressed that rapidanti-body testing kits should be used only for surveillance and said it hadevaluated the kits from Wondfo and Livzon in field conditions.
After the ICMR's decision, China on Tuesday said that its products meet quality standards and are exported to many other countries.
The spokesperson of Chinese Embassy Ji Rong in a statement said that the quality of medical products exported from China is prioritized. It is unfair and irresponsible for certain individuals to label Chinese products as faulty and look at issues with pre-emptive prejudice.
He further stated that both Wondfo and Livzon had clarified thattheir testing kits had been certified by China's National Medical ProductsAdministration (NMPA), meet the quality standards China and importingcountries, and had also been validated and approved by ICMR through theNational Institute of Virology (NIV) in Pune.
India has placed orders for hundreds of thousands oftesting kits and millions of personal protective equipment (PPE) kits withChinese firms.
Assam has also bought 50,000 personal protectiveequipment (PPE) kits apart from rapid test kits from Guangzhou city in China.
The PPEs have been imported from China to be used bythe doctors and nurses while fighting against COVID19 in the state.
